Dawaa Reference

Drug profile

Nystatin

Adult, child, renal, hepatic, pregnancy and breastfeeding information, with the source named on every line.

DRUG INFORMATION

  ADULT
    - Very moist lesions are best treated with the topical dusting powder. Adults and
      Pediatric Patients (Neonates and Older) Apply to candidal lesions two or three
      times daily until healing is complete. For fungal infection of the feet caused by
      Candida species, the powder should be dusted on the feet, as well as, in all foot
      wear.
      Source: US FDA label for nystatin (Nyamyc), section 'dosage and administration',
      retrieved 2026-08-29

  CHILD
    - Safety and effectiveness have been established in the pediatric population from
      birth to 16 years. [see DOSAGE AND ADMINISTRATION ].
      Source: US FDA label for nystatin (Nyamyc), section 'pediatric use', retrieved
      2026-08-29
    - Very moist lesions are best treated with the topical dusting powder. Adults and
      Pediatric Patients (Neonates and Older) Apply to candidal lesions two or three
      times daily until healing is complete. For fungal infection of the feet caused by
      Candida species, the powder should be dusted on the feet, as well as, in all foot
      wear.
      Source: US FDA label for nystatin (Nyamyc), section 'dosage and administration',
      retrieved 2026-08-29

  RENAL IMPAIRMENT
    - No kidney-impairment dose in this label. Not a statement that none is needed.
      Source: Read and found silent: the US FDA label for nystatin (Nyamyc), retrieved
      2026-08-29

  HEPATIC IMPAIRMENT
    - No liver-impairment dose in this label. Not a statement that none is needed.
      Source: Read and found silent: the US FDA label for nystatin (Nyamyc), retrieved
      2026-08-29

  PREGNANCY
    - Teratogenic Effects Animal reproduction studies have not been conducted with any
      nystatin topical preparation.
      Source: US FDA label for nystatin (Nyamyc), section 'pregnancy', retrieved
      2026-08-29
    - It also is not known whether theses preparations can cause fetal harm when used by
      a pregnant woman or can affect reproductive capacity.
      Source: US FDA label for nystatin (Nyamyc), section 'pregnancy', retrieved
      2026-08-29
    - Nyamyc® (Nystatin Topical Powder, USP) should be prescribed for a pregnant woman
      only if the potential benefit to the mother outweighs the potential risk to the
      fetus.
      Source: US FDA label for nystatin (Nyamyc), section 'pregnancy', retrieved
      2026-08-29

  BREASTFEEDING
    - It is not known whether nystatin is excreted in human milk.
      Source: US FDA label for nystatin (Nyamyc), section 'nursing mothers', retrieved
      2026-08-29
    - Caution should be exercised when nystatin is prescribed for a nursing woman.
      Source: US FDA label for nystatin (Nyamyc), section 'nursing mothers', retrieved
      2026-08-29